TrialFrontiers in immunology2024

Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.

Chel Hun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.